These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21261645)

  • 1. Chemopreventive effects of resveratrol and resveratrol derivatives.
    Szekeres T; Saiko P; Fritzer-Szekeres M; Djavan B; Jäger W
    Ann N Y Acad Sci; 2011 Jan; 1215():89-95. PubMed ID: 21261645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol and resveratrol analogues--structure-activity relationship.
    Szekeres T; Fritzer-Szekeres M; Saiko P; Jäger W
    Pharm Res; 2010 Jun; 27(6):1042-8. PubMed ID: 20232118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol and derivatives for the prevention and treatment of cancer.
    Fulda S
    Drug Discov Today; 2010 Sep; 15(17-18):757-65. PubMed ID: 20692359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent inhibitory effects of resveratrol derivatives on progression of prostate cancer cells.
    Yoo KM; Kim S; Moon BK; Kim SS; Kim KT; Kim SY; Choi SY
    Arch Pharm (Weinheim); 2006 May; 339(5):238-41. PubMed ID: 16619281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol analogs: promising chemopreventive agents.
    Ogas T; Kondratyuk TP; Pezzuto JM
    Ann N Y Acad Sci; 2013 Jul; 1290():21-9. PubMed ID: 23855462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
    Aggarwal BB; Bhardwaj A; Aggarwal RS; Seeram NP; Shishodia S; Takada Y
    Anticancer Res; 2004; 24(5A):2783-840. PubMed ID: 15517885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells.
    Wang TT; Schoene NW; Kim YS; Mizuno CS; Rimando AM
    Mol Nutr Food Res; 2010 Mar; 54(3):335-44. PubMed ID: 20077416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The basis for the chemopreventive action of resveratrol.
    Roemer K; Mahyar-Roemer M
    Drugs Today (Barc); 2002 Aug; 38(8):571-80. PubMed ID: 12582422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention in experimental animals.
    Namasivayam N
    Ann N Y Acad Sci; 2011 Jan; 1215():60-71. PubMed ID: 21261642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comprehensive Review on the Chemotherapeutic Potential of Piceatannol for Cancer Treatment, with Mechanistic Insights.
    Seyed MA; Jantan I; Bukhari SN; Vijayaraghavan K
    J Agric Food Chem; 2016 Feb; 64(4):725-37. PubMed ID: 26758628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol and cellular mechanisms of cancer prevention.
    Shukla Y; Singh R
    Ann N Y Acad Sci; 2011 Jan; 1215():1-8. PubMed ID: 21261635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of resveratrol in breast cancer cell lines: impact of sulfotransferase 1A1 expression on cell growth inhibition.
    Murias M; Miksits M; Aust S; Spatzenegger M; Thalhammer T; Szekeres T; Jaeger W
    Cancer Lett; 2008 Mar; 261(2):172-82. PubMed ID: 18082939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol oligomers for the prevention and treatment of cancers.
    Xue YQ; Di JM; Luo Y; Cheng KJ; Wei X; Shi Z
    Oxid Med Cell Longev; 2014; 2014():765832. PubMed ID: 24799982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemopreventive and chemotherapeutic effect of trans-resveratrol and its analogues in cancer].
    Mikstacka R; Ignatowicz E
    Pol Merkur Lekarski; 2010 Jun; 28(168):496-500. PubMed ID: 20642113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol and its analogues: promising antitumor agents.
    Huang X; Zhu HL
    Anticancer Agents Med Chem; 2011 Jun; 11(5):479-90. PubMed ID: 21524243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer.
    Kumar A; Rimando AM; Levenson AS
    Ann N Y Acad Sci; 2017 Sep; 1403(1):15-26. PubMed ID: 28662290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol--a prostate cancer chemopreventive agent?
    Ratan HL; Steward WP; Gescher AJ; Mellon JK
    Urol Oncol; 2002; 7(6):223-7. PubMed ID: 12504842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activity of 3-chloro-azetidin-2-one derivatives having interesting antiproliferative activity on human breast cancer cell lines.
    Chimento A; Sala M; Gomez-Monterrey IM; Musella S; Bertamino A; Caruso A; Sinicropi MS; Sirianni R; Puoci F; Parisi OI; Campana C; Martire E; Novellino E; Saturnino C; Campiglia P; Pezzi V
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6401-5. PubMed ID: 24119558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Chemoprevention by Resveratrol: The p53 Tumor Suppressor Protein as a Promising Molecular Target.
    Ferraz da Costa DC; Fialho E; Silva JL
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28629161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer.
    Delmas D; Lançon A; Colin D; Jannin B; Latruffe N
    Curr Drug Targets; 2006 Apr; 7(4):423-42. PubMed ID: 16611030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.